COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Cash Flow Analysis including operating cash flow, investing cash flow, financing cash flow, free cash flow, cash flow from operations, cash flow from investing, cash flow from financing. Compare cash flow against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Cash Flow Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Reveals whether the business's core operations generate sufficient cash to cover expenses, fund growth, and return capital to shareholders. Sustainable free cash flow is often a key indicator of long-term value creation.

Operating Cash Flow per Share

121.70

Increased from previous period

Operating Cash Flow per share above $10 – Remarkably strong. Warren Buffett would verify if this high level is consistent across cycles.

Free Cash Flow per Share

121.70

Increased from previous period

FCF/share above $5 – Strong leftover cash post-capex. Warren Buffett would examine reinvestment opportunities or dividends.

Capex-to-Operating Cash Flow

No Data

No Data available this quarter, please select a different quarter.

Income Quality Ratio (OCF / Net Income)

1.90

Increased from previous period

1.5–2 ratio – Good alignment of earnings and cash. Seth Klarman would look at historical stability of OCF.

Operating Cash Flow-to-Sales Ratio

4.11%

Increased from previous period

OCF-to-sales under 5% – Very poor. Howard Marks would consider it a serious red flag for cash-conversion efficiency.

Select Chart Metric:

3349.T Cash Flow Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Operating Cash Flow per Share

121.70

Increased from previous period

Operating Cash Flow per share above $10 – Remarkably strong. Warren Buffett would verify if this high level is consistent across cycles.

Free Cash Flow per Share

121.70

Increased from previous period

FCF/share above $5 – Strong leftover cash post-capex. Warren Buffett would examine reinvestment opportunities or dividends.

Capex-to-Operating Cash Flow

No Data

No Data available this quarter, please select a different quarter.

Income Quality Ratio (OCF / Net Income)

1.90

Increased from previous period

1.5–2 ratio – Good alignment of earnings and cash. Seth Klarman would look at historical stability of OCF.

Operating Cash Flow-to-Sales Ratio

4.11%

Increased from previous period

OCF-to-sales under 5% – Very poor. Howard Marks would consider it a serious red flag for cash-conversion efficiency.

Select Chart Metric: